CIK 0001831828 · Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812744449
- Phone
- 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-05 | Turner William D. Chief Development Officer | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2024-01-03 | Brenner Robert Chief Medical Officer | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2023-12-29 | Fordyce Marshall President and CEO | Option exercise | +516 | $2.32 | $1K | 243,877 |
| 2023-12-29 | Fordyce Marshall President and CEO | Option exercise | +13,000 | $2.90 | $38K | 256,877 |
| 2023-12-29 | Fordyce Marshall President and CEO | Option exercise · Stock Option (Right to Buy) | −516 | 0 | ||
| 2023-12-29 | Fordyce Marshall President and CEO | Option exercise · Stock Option (Right to Buy) | −13,000 | 874,212 | ||
| 2023-12-20 | Grant Sean CHIEF FINANCIAL OFFICER | Gift | −636 | 18,021 | ||
| 2023-08-21 | Lin Celia Chief Medical Officer | Sale 10b5-1 | −1,490 | $16.65 | $25K | 11,010 |
| 2023-08-21 | Curley Joanne Chief Development Officer | Sale 10b5-1 | −1,490 | $16.66 | $25K | 26,962 |
| 2023-08-21 | Fordyce Marshall President and CEO | Sale 10b5-1 | −5,210 | $16.66 | $87K | 243,361 |
| 2023-07-24 | Grant Sean CHIEF FINANCIAL OFFICER | Gift | −1,620 | 18,657 | ||
| 2023-07-24 | Grant Sean CHIEF FINANCIAL OFFICER | Gift | +1,620 | 1,620 | ||
| 2023-07-05 | Young Joseph R SVP, Finance, Chief Acct Offcr | Option exercise | +10,000 | $3.94 | $39K | 32,679 |
| 2023-07-05 | Young Joseph R SVP, Finance, Chief Acct Offcr | Option exercise · Stock Option (right to buy) | −10,000 | 66,810 | ||
| 2023-03-14 | Grant Sean CHIEF FINANCIAL OFFICER | Gift | −14,285 | 35,648 | ||
| 2023-03-14 | Grant Sean CHIEF FINANCIAL OFFICER | Gift | +14,285 | 15,277 | ||
| 2022-08-17 | Carlyle Group Inc. 10% owner | Option exercise | +9,925 | $11.00 | $109K | 2,970,156 |
| 2022-08-17 | Carlyle Group Inc. 10% owner | Sale | −3,281 | $19.88 | $65K | 2,966,875 |
| 2022-08-17 | Carlyle Group Inc. 10% owner | Sale | −6,472 | $20.42 | $132K | 2,960,403 |
| 2022-08-17 | Carlyle Group Inc. 10% owner | Sale | −172 | $21.07 | $4K | 2,960,231 |
Page 16 of 17 · 321 trades